355 related articles for article (PubMed ID: 18164839)
1. Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma.
Hara W; Loo BW; Goffinet DR; Chang SD; Adler JR; Pinto HA; Fee WE; Kaplan MJ; Fischbein NJ; Le QT
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):393-400. PubMed ID: 18164839
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
3. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
[TBL] [Abstract][Full Text] [Related]
4. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome.
Thiagarajan A; Lin K; Tiong CE; Tan LK; Loh TK; Goh BC; Lu JJ
Laryngoscope; 2006 Jun; 116(6):938-43. PubMed ID: 16735885
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiosurgery plus intracavitary irradiation in the salvage of nasopharyngeal carcinoma.
Low JS; Chua ET; Gao F; Wee JT
Head Neck; 2006 Apr; 28(4):321-9. PubMed ID: 16287135
[TBL] [Abstract][Full Text] [Related]
6. Treatment results of 59 young patients with nasopharyngeal carcinoma.
Selek U; Ozyar E; Ozyigit G; Varan A; Buyukpamukcu M; Atahan IL
Int J Pediatr Otorhinolaryngol; 2005 Feb; 69(2):201-7. PubMed ID: 15656953
[TBL] [Abstract][Full Text] [Related]
7. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of brachytherapy and fractionated stereotactic radiotherapy boost for persistent nasopharyngeal carcinoma.
Yau TK; Sze WM; Lee WM; Yeung MW; Leung KC; Hung WM; Chan WI
Head Neck; 2004 Dec; 26(12):1024-30. PubMed ID: 15390194
[TBL] [Abstract][Full Text] [Related]
9. Experience in fractionated stereotactic body radiation therapy boost for newly diagnosed nasopharyngeal carcinoma.
Chen HH; Tsai ST; Wang MS; Wu YH; Hsueh WT; Yang MW; Yeh IC; Lin JC
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1408-14. PubMed ID: 17126207
[TBL] [Abstract][Full Text] [Related]
10. Brachytherapy boost for T1/T2 nasopharyngeal carcinoma.
Yeo R; Fong KW; Hee SW; Chua ET; Tan T; Wee J
Head Neck; 2009 Dec; 31(12):1610-8. PubMed ID: 19536853
[TBL] [Abstract][Full Text] [Related]
11. Soft tissue sarcomas treated with postoperative external beam radiotherapy with and without low-dose-rate brachytherapy.
Andrews SF; Anderson PR; Eisenberg BL; Hanlon AL; Pollack A
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):475-80. PubMed ID: 15145165
[TBL] [Abstract][Full Text] [Related]
12. External beam radiotherapy with endocavitary boost for nasopharyngeal cancer: treatment results and late toxicity after extended follow-up.
Schinagl DA; Marres HA; Kappelle AC; Merkx MA; Pop LA; Verstappen SM; Kaanders JH
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):689-95. PubMed ID: 20231060
[TBL] [Abstract][Full Text] [Related]
13. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma: an evaluation of response and toxicity.
Lu JJ; Shakespeare TP; Thiagarajan A; Zhang X; Liang L; Tan S
Laryngoscope; 2005 May; 115(5):806-10. PubMed ID: 15867644
[TBL] [Abstract][Full Text] [Related]
14. Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma.
Le QT; Tate D; Koong A; Gibbs IC; Chang SD; Adler JR; Pinto HA; Terris DJ; Fee WE; Goffinet DR
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1046-54. PubMed ID: 12829140
[TBL] [Abstract][Full Text] [Related]
15. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG).
Teo PM; Leung SF; Tung SY; Zee B; Sham JS; Lee AW; Lau WH; Kwan WH; Leung TW; Chua D; Sze WM; Au JS; Yu KH; O SK; Kwong D; Yau TK; Law SC; Sze WK; Au G; Chan AT
Radiother Oncol; 2006 Apr; 79(1):27-33. PubMed ID: 16626829
[TBL] [Abstract][Full Text] [Related]
16. Outcome of fractionated stereotactic radiotherapy for 90 patients with locally persistent and recurrent nasopharyngeal carcinoma.
Wu SX; Chua DT; Deng ML; Zhao C; Li FY; Sham JS; Wang HY; Bao Y; Gao YH; Zeng ZF
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):761-9. PubMed ID: 17601682
[TBL] [Abstract][Full Text] [Related]
17. Nasopharyngeal carcinoma treated by radical radiotherapy alone: Ten-year experience of a single institution.
Yi JL; Gao L; Huang XD; Li SY; Luo JW; Cai WM; Xiao JP; Xu GZ
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):161-8. PubMed ID: 16542792
[TBL] [Abstract][Full Text] [Related]
18. Nasopharyngeal cancer in the Middle East: experience of the American University of Beirut Medical Center.
Geara FB; Nasr E; Tucker SL; Brihi E; Zaytoun G; Hadi U; Salem Z; El Saghir N; Issa P; Shamseddine A
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1408-15. PubMed ID: 15817344
[TBL] [Abstract][Full Text] [Related]
19. Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group.
Yu KH; Leung SF; Tung SY; Zee B; Chua DT; Sze WM; Law SC; Kam MK; Leung TW; Sham JS; Lee AW; Au JS; Hui EP; Sze WK; Cheng AC; Yau TK; Ngan RK; Wong FC; Au GK; Chan AT;
Head Neck; 2005 May; 27(5):397-405. PubMed ID: 15726589
[TBL] [Abstract][Full Text] [Related]
20. Hyperfractionated radiotherapy in locally advanced nasopharyngeal cancer. An analysis of 43 consecutive patients.
Jereczek-Fossa BA; Morra A; DeBraud F; Alterio D; Mazzetta C; Rocca A; Catalano G; Bianchi L; Pasetti M; Chiesa F; Bruschini R; Orecchia R
Strahlenther Onkol; 2004 Jul; 180(7):425-33. PubMed ID: 15241530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
